These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Production and purification of eta (ETA) precipitinogen, species-specific to mycobacterium tuberculosis and its intradermal reactivity. Hirai T; Yamanouchi T Dev Biol Stand; 1986; 58 ( Pt B)():565-8. PubMed ID: 3111903 [TBL] [Abstract][Full Text] [Related]
4. Relative cross reactivity of habanin, lepromin and tuberculin in guinea pigs sensitized with homologous and heterologous mycobacteria. Singh NB; Srivastava A; Gupta HP; Kumar A; Chaturvedi VK Indian J Lepr; 1988 Jul; 60(3):407-12. PubMed ID: 3143770 [TBL] [Abstract][Full Text] [Related]
5. [Purification, characterization and immunological study of 2 protein antigens of the BCG strain Mycobacterium bovis]. De Bruyn J; Turneer M Bull Mem Acad R Med Belg; 1988; 143(1-2):157-70. PubMed ID: 3052672 [No Abstract] [Full Text] [Related]
6. [Attempts at isolation and characterization of immunogenically active fractions from Mycobacterium tuberculosis and Mycobacterium bovis (BCG). IV. Immunobiologic properties of the fractions]. Klose F; Schallehn G Z Immunitatsforsch Allerg Klin Immunol; 1966 Sep; 131(3):219-35. PubMed ID: 4231180 [No Abstract] [Full Text] [Related]
7. Evaluation of Mycobacterium tuberculosis specific RD antigens for delayed type hypersensitivity responses in guinea pig. Kalra M; Khuller GK; Sheikh JA; Verma I Indian J Exp Biol; 2010 Feb; 48(2):117-23. PubMed ID: 20455320 [TBL] [Abstract][Full Text] [Related]
8. MPB70, a unique antigenic protein isolated from the culture filtrate of BCG substrain Tokyo. Nagai S; Miura K; Tokunaga T; Harboe M Dev Biol Stand; 1986; 58 ( Pt B)():511-6. PubMed ID: 3301461 [No Abstract] [Full Text] [Related]
9. [Immunologic characteristics of monoclonal antibodies to Mycobacterium Bovis and four affinity-purified mycobacterial antigens]. Liashchenko KP; Bobrovnik CA; Gorbenko EV; Kolesnikova IN; Bukhanevich AM; Liashko ED; Komissarenko SB Probl Tuberk; 1993; (5):41-4. PubMed ID: 7507592 [TBL] [Abstract][Full Text] [Related]
10. Induction kinetics of delayed hypersensitivity towards Mycobacterium tuberculosis and M. avium: analysis of cross-reactions elicited by PPD-tuberculin and PPD-B. David HL; Selin M; Gontijo Filho PP; Beam E; Sud M Rev Bras Pesqui Med Biol; 1978 Dec; 11(6):313-9. PubMed ID: 108772 [No Abstract] [Full Text] [Related]
11. Expanding the antigenic repertoire of BCG improves protective efficacy against aerosol Mycobacterium tuberculosis infection. Palendira U; Spratt JM; Britton WJ; Triccas JA Vaccine; 2005 Feb; 23(14):1680-5. PubMed ID: 15705472 [TBL] [Abstract][Full Text] [Related]
12. Delayed-type hypersensitivity to a recombinant mycobacterial antigen, MPB64, in guinea pigs sensitized to Mycobacterium tuberculosis or Mycobacterium bovis BCG. Haga S; Yamaguchi R; Nagai S; Matsuo K; Yamazaki A; Nakamura RM J Leukoc Biol; 1995 Feb; 57(2):221-5. PubMed ID: 7531745 [TBL] [Abstract][Full Text] [Related]
13. Antigen study of Mycobacteria tuberculosis and BCG for detection of postvaccinal and infectious allergy. Mitinskaya LA J Hyg Epidemiol Microbiol Immunol; 1975; 19(4):508-10. PubMed ID: 812912 [No Abstract] [Full Text] [Related]
14. [Immunologic characterization of fractions of the BCG strain of M. bovis isolated by chromatofocusing]. Nyabenda J; Pierre M; Keuterickx F; de Backer P Dev Biol Stand; 1986; 58 ( Pt A)():43-52. PubMed ID: 3297875 [No Abstract] [Full Text] [Related]
15. Clinical evaluation of the recombinant 38 kDa protein of Mycobacterium tuberculosis. He XY; Luo YA; Zhang XG; Liu YD; Wang ZY; Luo FZ; Zhang JP; Wang Q; Yan SM; Wang YJ; Ma LF; Guo J; Dong YJ; Huang XY; Zhuang YH Scand J Infect Dis; 2008; 40(2):121-6. PubMed ID: 17852901 [TBL] [Abstract][Full Text] [Related]
16. Mycobacterial sensitivity elicited with a PPD devoided of the majority of the antigens common with BCG. Results on healthy-BCG vaccinated and tuberculous children. Stavri D; Claiciu I; Bărbulescu R; Stavri H; Niculescu D; Calciu B; Calciu M Arch Roum Pathol Exp Microbiol; 1983; 42(2-3):221-6. PubMed ID: 6424630 [No Abstract] [Full Text] [Related]
17. Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis. Sun R; Skeiky YA; Izzo A; Dheenadhayalan V; Imam Z; Penn E; Stagliano K; Haddock S; Mueller S; Fulkerson J; Scanga C; Grover A; Derrick SC; Morris S; Hone DM; Horwitz MA; Kaufmann SH; Sadoff JC Vaccine; 2009 Jul; 27(33):4412-23. PubMed ID: 19500523 [TBL] [Abstract][Full Text] [Related]
18. Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate with circulating IFN-gamma producing T-cells. Badell E; Nicolle F; Clark S; Majlessi L; Boudou F; Martino A; Castello-Branco L; Leclerc C; Lewis DJ; Marsh PD; Gicquel B; Winter N Vaccine; 2009 Jan; 27(1):28-37. PubMed ID: 18977269 [TBL] [Abstract][Full Text] [Related]
19. Immunological evaluation of a 12-kilodalton protein of Mycobacterium tuberculosis by enzyme-linked immunosorbent assay. Deshpande RG; Khan MB; Navalkar RG Tuber Lung Dis; 1993 Dec; 74(6):382-7. PubMed ID: 8136491 [TBL] [Abstract][Full Text] [Related]
20. Serological response in leprosy and tuberculosis patients to the 18-kDa antigen of Mycobacterium leprae and antigen 85B of Mycobacterium bovis BCG. Vikerfors T; Olcén P; Wiker H; Watson JD Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):571-80. PubMed ID: 8151188 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]